Other safety alerts
|
| |
| Australia: Safety advisory: Iverjohn-12 & Ivervid-12 tablets |
| |
The Therapeutic Goods Administration (TGA) are continuing to see imports of counterfeit ivermectin. This alert is in addition to previous warnings issued in December 2021, March 2022, and October 2024, regarding the importation of counterfeit ivermectin.
The TGA has tested a further 2 imported, unregistered ivermectin products and found they are counterfeit under the Therapeutic Goods Act 1989. Both of these ivermectin products were subject to the previous alerts in 2021 and 2022, with this latest testing showing the goods are still counterfeit.
Laboratory analysis confirmed that both Iverjohn-12 and Ivervid-12 contain less than the stated 12mg of the active pharmaceutical ingredient, ivermectin.
As with the previous warnings issued, these products were purchased online from an overseas website and were not bought from an Australian pharmacy. Consumers are advised to exercise extreme caution when purchasing medicines from unknown overseas websites.
Ivermectin is used orally for the treatment of a variety of nematode (roundworm) infections and treatment of ectoparasitic infections.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/news/safety-alerts/iverjohn-12-ivervid-12-tablets
In Hong Kong, the above products are not registered pharmaceutical products. Related news was previously issued by TGA, and was posted on the Drug Office website on 14 Dec 2021, 4 Mar 2022 and 28 Oct 2024.
Ends/Wednesday, Jun 25, 2025
Issued at HKT 15:45
|
| |
|
